![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Bentham Science Publishers
E-ISSN: 1875-5933|3|1|35-42
ISSN: 1568-010X
Source: Current Drug Targets. Inflammation & Allergy, Vol.3, Iss.1, 2004-03, pp. : 35-42
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Biologics in Inflammatory Immune-mediated Systemic Diseases
Current Pharmaceutical Biotechnology, Vol. 18, Iss. 12, 2018-03 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 18, Iss. 1, 2017-12 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
NPY and Receptors in Immune and Inflammatory Diseases
Current Topics in Medicinal Chemistry, Vol. 7, Iss. 17, 2007-09 ,pp. :